ArticleJournal for immunotherapy of cancer2026
Targeting the novel immune checkpoint KLRG1 is markedly therapeutic against cancer through multiple lymphocyte subsets.
Tyler Andrew Jones et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.